Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01231646 · ClinicalTrials.gov registry record
Does Valproate Increase Levels of Folate Receptor Autoantibodies in Women?
A clinical trial of Epilepsy and Psychiatric or Mood Diseases or Conditions, sponsored by Northwell Health.
- Completed
- Registry status
- 38
- Enrollment target
- 1
- Study location
NCT01231646 is a study of Epilepsy and Psychiatric or Mood Diseases or Conditions that has completed, run by Northwell Health. The registered enrollment target is 38 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01231646, a study of Epilepsy and Psychiatric or Mood Diseases or Conditions, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
Women who take folate (folic acid) before getting pregnant can lower the risk of giving birth to infant with certain birth defects. However, some medications may affect the action of folate. The purpose of this study is to compare the effect of two anti-epileptic drugs on how folate works in our body.
Conditions Studied
Interventions
- OTHER No intervention
Study Locations (1)
New York
- North Shore Long Island Jewish Health System - Great Neck
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2010-10 |
| Est. Completion | 2015-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01231646
The ClinicalTrials.gov registry entry for NCT01231646 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (96% lower). The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.
NCT01231646 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01231646 about?
NCT01231646 is a clinical study titled "Does Valproate Increase Levels of Folate Receptor Autoantibodies in Women?". Women who take folate (folic acid) before getting pregnant can lower the risk of giving birth to infant with certain birth defects. However, some medications may affect the action of folate. The purpose of this study is to compare the effect of two anti-epileptic drugs on how folate works in our bod...
What is the current status of trial NCT01231646?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2010-10. Estimated completion is 2015-07.
What conditions does trial NCT01231646 study?
This clinical trial studies the following conditions: Epilepsy, Psychiatric or Mood Diseases or Conditions.
What interventions are being tested in trial NCT01231646?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT01231646?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01231646 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
RECRUITING
-
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
RECRUITING
-
SeizEAR Safety Study
RECRUITING · NA
-
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RECRUITING
-
Tumor Related Epilepsy
RECRUITING
-
Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.